Northern Arizona Healthcare is offering monoclonal antibody (mAB) treatment for COVID-19 at dedicated clinics in Flagstaff and Cottonwood with appointments for treatment available as early as February 10, 2022. Monoclonal antibody treatments will be offered at no cost to patients who receive this care. Monoclonal antibody treatment for COVID-19 is available by appointment only. At this time, mAB infusion is reserved for patients over 65 or those with certain high-risk conditions.
The clinics will be staffed thanks to resources provided by the Federal Emergency Management Agency (FEMA). When Northern Arizona Healthcare learned monoclonal antibody treatments for COVID-19 would be made available through FEMA, we took the steps necessary to make these treatments available to our community at clinics in Flagstaff and Cottonwood.
Physicians at the mAB treatment clinics will be administering sotrovimab, which is the most effective option for treating the Omicron variant. Monoclonal antibody treatments, which are administered via an intravenous infusion, can help reduce the severity of COVID-19 symptoms as well as reduce the risk that a patient may need to be admitted to a hospital for care and treatment.
Please call 928-773-2301 or 1-833-708-0894 if you believe you may be eligible for mAB treatment for COVID-19. A member of the Northern Arizona Healthcare and FEMA team will assist you in determining eligibility and scheduling an appointment for treatment.
To receive monoclonal antibody treatment for COVID-19, community members who may be eligible must contact us within 10 days of onset of COVID-19 symptoms AND within 10 days of a positive PCR test for COVID-19 to be eligible for mAB treatment. At-home rapid tests will not be accepted.
To receive this medication, a person meet the following criteria:
- Be 18 years of age or older, AND
- In the outpatient setting, AND
- Have onset of symptoms must be less than 10 days prior to treatment, AND
- Have positive COVID viral diagnostic test (not an antibody test), AND
- Meet high risk criteria which includes:
- Age >/=65, OR
- Obesity, OR
- Chronic kidney or liver disease, OR
- Diabetes, OR
- Weakened Immune system, OR
Heart disease (including high blood pressure, congestive heart failure, and congenital heart disease), OR
Lung disease (e.g., COPD, moderate-severe asthma, interstitial lung disease, pulmonary Hypertension, cystic fibrosis, etc.), OR
Neurologic or neurodevelopmental disorder (e.g., Stroke, cerebral palsy, downs syndrome)
Sickle cell disease, OR
Need for a medical device such as tracheostomy or gastrostomy, OR
Other medical conditions that may increase risk for progression to severe COVID-19 (e.g., race/ethnicity, substance abuse, pregnancy, complex medical condition)
Talk with your health care provider about treatments that are right for you, including if you have other medical conditions not listed above.
Click the button below for more information about COVID-19 Treatment
Click the buttons below for more information from the Arizona Department of Health Services on COVID-19 antivirals.